Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/2940| Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | |
| South Andrew M.. Tomlinson Laurie. Edmonston Daniel. Hiremath Swapnil. Sparks Matthew A.. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1038/s41581-020-0279-4 | |
| The current COVID-19 pandemic is associated with unprecedented morbidity and mortality. Early reports suggested an association between disease severity and hypertension but did not account for sources of confounding. However, the responsible virus — SARS-CoV-2 — gains entry to host cells via angiotensin-converting enzyme 2 (ACE2), highlighting the need to understand the relationship between the virus and the renin–angiotensin system (RAS) and how this might be affected by RAS inhibitors. | |
| Nature Reviews Nephrology | |
| 2020 | |
| Artículo | |
| https://www.nature.com/articles/s41581-020-0279-4.pdf | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1103003.pdf | 1.03 MB | Adobe PDF | Visualizar/Abrir |